Run Zhuang

604 total citations
11 papers, 353 citations indexed

About

Run Zhuang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Run Zhuang has authored 11 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Run Zhuang's work include Diabetes Treatment and Management (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (3 papers). Run Zhuang is often cited by papers focused on Diabetes Treatment and Management (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (3 papers). Run Zhuang collaborates with scholars based in United States. Run Zhuang's co-authors include Jane Zhang, Jian Luo, Daniel C.-H. Lin, Jonathan B. Houze, Gayathri Swaminath, Paul J. Dransfield, Sean P. Brown, Qi Guo, Marc Vimolratana and Thanhvien Tran and has published in prestigious journals such as PLoS ONE, Biochemistry and Alzheimer s & Dementia.

In The Last Decade

Run Zhuang

10 papers receiving 339 citations

Peers

Run Zhuang
Kathy Nguyen United States
Marc Vimolratana United States
Juerg Lehmann United States
Edward J. Brady United States
Corey Miller United States
Eugenia Sergeev United Kingdom
Kathy Nguyen United States
Run Zhuang
Citations per year, relative to Run Zhuang Run Zhuang (= 1×) peers Kathy Nguyen

Countries citing papers authored by Run Zhuang

Since Specialization
Citations

This map shows the geographic impact of Run Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Zhuang more than expected).

Fields of papers citing papers by Run Zhuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Zhuang. The network helps show where Run Zhuang may publish in the future.

Co-authorship network of co-authors of Run Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Run Zhuang. A scholar is included among the top collaborators of Run Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Run Zhuang. Run Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Deli, Hana Florian, Weining Robieson, et al.. (2025). Using AI‐generated digital twins to boost clinical trial efficiency in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(4). e70181–e70181.
3.
Brown, Sean P., Paul J. Dransfield, Marc Vimolratana, et al.. (2018). Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. ACS Medicinal Chemistry Letters. 9(7). 757–760. 12 indexed citations
4.
Chen, Zhengjia, Zheng Li, Run Zhuang, et al.. (2017). Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile. PLoS ONE. 12(1). e0170187–e0170187. 7 indexed citations
5.
Zhang, Tonglin & Run Zhuang. (2016). Testing proportionality between the first-order intensity functions of spatial point processes. Journal of Multivariate Analysis. 155. 72–82. 4 indexed citations
6.
Ma, Zhihua, Daniel C.-H. Lin, Rajiv Sharma, et al.. (2015). Discovery of the imidazole-derived GPR40 agonist AM-3189. Bioorganic & Medicinal Chemistry Letters. 26(1). 15–20. 16 indexed citations
7.
Liu, Jiwen, Yingcai Wang, Zhihua Ma, et al.. (2014). Optimization of GPR40 Agonists for Type 2 Diabetes. ACS Medicinal Chemistry Letters. 5(5). 517–521. 37 indexed citations
8.
Luo, Jian, Gayathri Swaminath, Sean P. Brown, et al.. (2012). A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents. PLoS ONE. 7(10). e46300–e46300. 114 indexed citations
9.
Brown, Sean P., Paul J. Dransfield, Marc Vimolratana, et al.. (2012). Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist. ACS Medicinal Chemistry Letters. 3(9). 726–730. 68 indexed citations
10.
Lin, Daniel C.-H., Jane Zhang, Run Zhuang, et al.. (2011). AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents. PLoS ONE. 6(11). e27270–e27270. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026